Contraception Selection, Effectiveness, and Adverse Effects: A Review.
Teal S, Edelman A.
JAMA. 2021 Dec 28;326(24):2507-2518. doi: 10.1001/jama.2021.21392.
Unscheduled vaginal bleeding with progestin-only contraceptive use.
Zigler RE, McNicholas C.
Am J Obstet Gynecol. 2017 May;216(5):443-450. doi: 10.1016/j.ajog.2016.12.008. Epub 2016 Dec 14.
Long-acting reversible contraceptive (LARCs) methods.
Bahamondes L, Fernandes A, Monteiro I, Bahamondes MV.
Best Pract Res Clin Obstet Gynaecol. 2020 Jul;66:28-40. doi: 10.1016/j.bpobgyn.2019.12.002. Epub 2019 Dec 20.
Subdermal progestin implant contraception.
Darney PD.
Curr Opin Obstet Gynecol. 1991 Aug;3(4):470-6.
Difficult implant removals.
Voedisch A, Hugin M.
Curr Opin Obstet Gynecol. 2017 Dec;29(6):449-457. doi: 10.1097/GCO.0000000000000416.
One-year incidence of low libido in women using levonorgestrel subdermal implant as contraception. Cohort study. Armenia, Colombia, 2014-2019.
Espitia De La Hoz FJ.
Rev Colomb Obstet Ginecol. 2021 Mar 30;72(1):33-42. doi: 10.18597/rcog.3520.
Norplant: subdermal implant system for long-term contraception.
Shoupe D, Mishell DR.
Am J Obstet Gynecol. 1989 May;160(5 Pt 2):1286-92. doi: 10.1016/s0002-9378(89)80014-6.
Trends in subdermal contraceptive implant use in Mexico 2009-2018: A population-based study.
Darney BG, Fuentes-Rivera E, Corbin A, Saavedra-Avendano B, Schiavon R.
Int J Gynaecol Obstet. 2022 Feb;156(2):284-291. doi: 10.1002/ijgo.13744. Epub 2021 Jun 12.
A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.
Moray KV, Chaurasia H, Sachin O, Joshi B.
Reprod Health. 2021 Jan 6;18(1):4. doi: 10.1186/s12978-020-01054-y.
Choice of contraceptives.
[No authors listed]
Med Lett Drugs Ther. 2018 Oct 8;60(1557):161-168.
